Test Price
2,800 AED✅ Home Collection Available
USP8 Gene NGS Test for SPG59 (Hereditary Spastic Paraplegia Type 59) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل تسلسل جين USP8 لمرض الشلل النصفي التشنجي الوراثي من النوع 59 (SPG59) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 Accredited Processing.
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy (8 AM‑11 PM).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance by DHA‑licensed neurologist for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: دقة تشخيصية 99.9%، خدمة جمع منزلي معتمدة، إرشاد طبي بعد الفحص، والتحقق من التأمين مباشرة.
Overview
This Next‑Generation Sequencing (NGS) test analyzes the entire coding region of the USP8 gene to detect single‑nucleotide variants, small indels, and copy‑number changes causative of Hereditary Spastic Paraplegia Type 59 (SPG59). Delivered directly to UAE patients, the assay integrates the latest 2026 DHA‑recognized interpretation guidelines to provide a definitive molecular diagnosis.
| Parameter | Our USP8 NGS Test | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Precision | 99.9% analytical sensitivity; uniform coverage >100× | ∼98% per amplicon; prone to allele drop‑out |
| Method | NGS with orthogonal Sanger confirmation of all reported variants | Conventional Sanger sequencing of individual exons |
| Speed | 3–4 weeks from sample receipt | 4–6 weeks due to sequential exon processing |
Physician Insight & Safety Protocol
“As a neurologist, I recognize the emotional weight of a genetic diagnosis; however, molecular confirmation of SPG59 opens the door to personalized rehabilitation, disease‑modifying trials, and informed family planning. This test transforms uncertainty into a clear clinical pathway.” — Dr. PRABHAKAR REDDY, Consultant Neurologist (DHA Licence: 61713011)
⚠ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Genetic results must always be correlated with clinical findings.
Exclusion Criteria:
- Acute febrile illness or active infection at time of collection
- Inability to provide informed consent (for adults) or parental consent (minors per UAE CDS Law 2026)
- Whole‑blood transfusion within the last 30 days – may interfere with germline DNA analysis
Emergency Red Flags (seek immediate care):
- Sudden, severe worsening of gait or spasticity
- Acute visual loss or cranial nerve palsies
- New‑onset seizures or altered consciousness
Patient FAQ & Clinical Guidance
Q1. What is the clinical purpose of USP8 gene testing for SPG59?
This NGS test definitively diagnoses Hereditary Spastic Paraplegia Type 59 by identifying pathogenic USP8 variants, enabling targeted neurology care. It differentiates SPG59 from other causes of progressive lower‑limb spasticity and guides prognosis, treatment selection, and family screening.
يُستخدم اختبار تسلسل الجين USP8 بتقنية NGS لتأكيد تشخيص الشلل النصفي التشنجي الوراثي من النوع 59 من خلال الكشف عن الطفرات الممرضة، مما يتيح رعاية عصبية موجهة وفحص أفراد الأسرة المعرضين للخطر.
Q2. How is the sample collected for this test in Dubai and across the UAE?
A hospital‑grade phlebotomist visits your home for a simple blood draw or fingertip FTA card collection, respecting UAE cold‑chain protocols. The process is entirely mobile; whole blood, extracted DNA, or a single drop on an FTA card is accepted. Samples are transported at 2–8°C to our ISO‑certified laboratory.
يصل أخصائي سحب دم معتمد إلى منزلك لجمع العينة إما عن طريق الوريد أو بطاقة FTA عبر وخزة إصبع، مع الالتزام بمعايير النقل المبرد المعتمدة في الإمارات.
Q3. Why should I choose this DHA‑aligned genetic test over cheaper options?
Our DHA‑compliant test provides 99.9% diagnostic sensitivity, post‑test telephonic neurologist counselling, and direct insurance verification — eliminating hidden costs. Alternative low‑cost tests often lack ISO 9001:2015 accreditation, do not include pre‑ genetic counselling, and cannot guarantee data privacy under UAE Federal Decree‑Law No. 41 of 2024.
يضمن اختبارنا المعتمد من هيئة الصحة بدبي حساسية تشخيصية 99.9%، واستشارة هاتفية مع طبيب أعصاب بعد النتيجة، وتحققاً مباشراً مع شركات التأمين وفقاً للمرسوم بقانون اتحادي رقم 41 لسنة 2024.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians